The group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4927-4935

  Kasai, Masaaki ^a,b   Guerrero Santoro, Jennifer ^a   Friedman, Robert ^a   Leman, Eddy S ^a,b   Getzenberg, Robert H ^a,b   DeFranco, Donald B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; PAXILLIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; TRANSACTIVATION;

CYTOSKELETAL PROTEINS; HUMANS; MALE; NUCLEAR MATRIX; PAXILLIN; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0041438404     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Mooradian, A. D., Morley, J. E., and Korenman, S. G. Biological actions of androgens. Endocr. Rev., 8: 1-28, 1987.
2. Jenster, G. The role of androgen receptor in the development and progression of prostate cancer. Semin. Oncol., 26: 407-421, 1999.
3. Bourguet, W., Germain, P., and Gronemeyer, H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci., 21: 381-388, 2000.
4. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. The nuclear receptor superfamily: the second decade. Cell, 83: 835-839, 1995.
5. Cude, K. J., Dixon, S. C., Guo, Y., Lisella, J., and Figg, W. D. The androgen receptor: genetic considerations in the development and treatment of prostate cancer. J. Mol. Med., 77: 419-426, 1999.
6. Keller, E. T., Ershler, W. B., and Chang, C. The androgen receptor: a mediator of diverse responses. Front. Biosci., 1: d59-d71, 1996.
7. Slagsvold, T., Kraus, I., Fronsdal, K., and Saatcioglu, F. DNA binding-independent transcriptional activation by the androgen receptor through triggering of coactivators. J. Biol. Chem., 276: 31030-31036, 2001.
8. Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., and Peeters, B. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell. Biol., 19: 6085-6097, 1999.
9. Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., and Parker, M. G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRCI. Mol. Cell. Biol., 19: 8383-8392, 1999.
10. He, B., Minges, J. T., Lee, L. W., and Wilson, E. M. The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J. Biol. Chem., 277: 10226-10235, 2002.
11. Hsiao, P. W., and Chang, C. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J. Biol. Chem., 274: 22373-22379, 1999.
12. Dilworth, F. J., and Chambon, P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene. 20: 3047-3054, 2001.
13. Glass, C. K., and Rosenfeld, M. G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev., 14: 121-141, 1999.
14. Bannister, A. J., and Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature (Lond.), 384: 641-643, 1996.
15. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87: 953-959, 1996.
16. Boyes, J., Byfield, P., Nakatani, Y., and Ogoryzko, V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature (Lond.), 396: 594-598, 1998.
17. Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M. L., and Pestell, R. G. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem., 275: 20853-20860, 2000.
18. Martinez-Balbas, M. A., Bauer, U. M., Nielsen, S. J., Brehm, A., and Kouzarides, T. Regulation of E2F1 activity by acetylation. EMBO J., 15: 662-671, 2000.
19. Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., Aswad, D. W., and Stallcup, M. R. Regulation of transcription by a protein methyltransferase. Science (Wash. DC), 284: 2174-2177, 1999.
20. Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., and Evans, R. M. A transcriptional switch mediated by cofactor methylation. Science (Wash. DC), 294: 2507-2511, 2001.
21. Ma, Z. Q., Liu, Z., Ngan, E. S., and Tsai, S. Y. Cdc25B functions as a novel coactivator for the steroid receptors. Mol. Cell. Biol., 21: 8056-8067, 2001.
22. Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol., 19: 1182-1189, 1999.
23. Kang, H. Y., Yeh, S., Fujimoto, N., and Chang, C. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem., 274: 8570-8576, 1999.
24. 2-terminal associated coactivator. J. Biol. Chem., 275: 9308-9313, 2000.
25. Park, J. J., Irvine, R. A., Buchanan, G., Koh, S. S., Park, J. M., Tilley, W. D., Stallcup, M. R., Press, M. F., and Coetzee, G. A. Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor. Cancer Res., 60: 5946-5949, 2000.
26. Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., and Sun, Z. Linking β-catenin to androgen signaling pathway. J. Biol. Chem., 277: 11336-11344, 2002.
27. Fujimoto, N., Yeh, S., Kang, H. Y., Inui, S., Chang, H. C., Mizokami, A., and Chang, C. Cloning and characterization of androgen receptor coactivator. ARA55, in human prostate. J. Biol. Chem. 274: 8316-8321, 1999.
28. Yang, L., Guerrero, J., Hong, H., DeFranco, D. B., and Stallcup, M. R. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator. Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell, 11: 2007-2018, 2000.
29. Matsuya, M., Sasaki, H., Aoto, H., Mitaka, T., Nagura, K., Ohba, T., Ishino, M., Takahashi, S., Suzuki, R., and Sasaki, T. Cell adhesion kinase β forms a complex with a new member. Hic-5, of proteins localized at focal adhesions. J. Biol. Chem., 273: 1003-1014, 1998.
30. Thomas, S. M., Hagel, M., and Turner, C. E. Characterization of a focal adhesion protein. Hic-5, that shares extensive homology with paxillin. J. Cell Sci., 112: 181-190, 1999.
31. Schaller, M. D. Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 20: 6459-6472, 2001.
32. Turner, C. E. Paxillin and focal adhesion signaling. Nat. Cell Biol., 2: E231-E216, 2000.
33. Perez-Alvarado, G. C., Miles, C., Michelsen, J. W., Louis, H. A., Winge, D. R., Beckerle, M. C., and Summers, M. F. Structure of the carboxyl-terminal LIM domain from the cysteine rich protein CRP. Nat. Struct. Biol., 1: 388-398, 1994.
34. Dawid, I. B., Breen, J. J., and Toyama, R. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet., 14: 156-162, 1998.
35. Taira, M., Evrard, J. L., Steinmetz, A., and Dawid, I. B. Classification of LIM proteins. Trends Genet., 11: 431-432, 1995.
36. Nix, D. A., and Beckerle, M. C. Nuclear-cytoplasmic shuttling of focal contact protein, zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell Biol., 138: 1139-1147, 1997.
37. Petit, M. M. R., Fradelizi, J., Golsteyn, R. M., Ayoubi, T. A. Y., Menichi, B., Louvard, D., Van de Ven, W. J. M., and Friederich, E. LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. Mol. Biol., Cell, 11: 117-129, 2000.
38. Wang, Y., Dooher, J. E., Zhao, M. K., and Gilmore, T. D. Characterization of mouse Trip6: a putative intracellular signaling protein. Gene (Amst.), 234: 403-409, 1999.
39. Wang, Y., and Gilmore, T. D. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta, 1538: 260-272, 2001.
40. Lee, J. W., Choi, H-S., Gyuris, J., Brent, R., and Moore, D. D. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol., 9: 243-254, 1995.
41. Kanungo, J., Pratt, S. J., Marie, H., and Longmore, G. D. Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. Mol. Biol. Cell., 11: 3299-3313, 2000.
42. Aprikian, A. G., Tremblay, L., Han, K., and Chevalier, S. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J. Cancer, 72: 498-504, 1997.
43. Tremblay, L., Hauck, W., Aprikian, A. G., Begin, L. R., Chapdelaine, A., and Chevalier, S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer, 68: 164-171, 1996.
44. Tang, Y., Getzenberg, R. H., Vietmeier, B. N., Stallcup, M. R., Eggert, M., Renkawitz, R., and DeFranco, D. B. The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. Mol. Endocrinol., 12: 1420-1431, 1998.
45. Partin, A. W., Getzeriber, R. H., Carmichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I., and Coffey, D. S. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744-746, 1993.
46. Parr, C., Davies, G., Nakamura, T., Matsumoto, K., Mason, M. D., and Jiang, W. G. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochem. Biophys. Res. Commun., 285: 1330-1337, 2001.
47. Barrack, E. R. The nuclear matrix of the prostate contains acceptor sites for androgen receptors. Endocrinology, 113: 430-432, 1983.
48. van Steensel, B., Jenster, G., Damm, K., Brinkmann, A. O., and van Driel, R. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J. Cell. Biochem., 57: 465-478, 1995.
49. Fujita, H., Kamiguchi, K., Cho, D., Shibanuma, M., Morimoto, C., and Tachibana, K. Interaction of Hic-5, a senescence-related protein, with focal adhesion kinase. J. Biol. Chem., 273: 26516-26521, 1998.
50. Shibanuma, M., Mochizuki, E., Maniwa, R., Mashimo, J., Nishiya, N., Imai, S., Takano, T., Oshimura, M., and Nose, K. Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol. Cell. Biol., 17: 1224-1235, 1997.
51. Zhao, M. K., Wang, Y., Murphy, K., Yi, J., Beckerle, M. C., and Gilmore, T. D. LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor. Gene Exp., 8: 207-217, 1999.
52. Hong, H., Kohli, K., Garabedian, M. J., and Stallcup, M. R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol., 17: 2735-2744, 1997.
53. Sheng, H. Z., Zhadanov, A. B., Mosinger, B., Fujii, T., Bertuzzi, S., Grinberg, A., Lee, E. J., Huang, S-P., Mahon, K. A., and Westphal, H. The LIM homeobox gene Lhx-3 is essential for specification and proliferation of pituitary cell lineages. Science (Wash. DC), 256: 1555-1560, 1996.
54. Warren, A. J., Colledge, W. H., Carlton, M. B. L., Evans, M. J., Smith, A. J. H., and Rabbitts, T. H. The oncogenic, cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell, 78: 45-58, 1994.
55. Hagel, M., George, E. L., Kim, A., Tamimi, R., Opitz, S. L., Turner, C. E., Imamoto, A., and Thomas, S. M. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22: 901-915, 2002.
56. Fimia, G.-M., De Cesare, D., and Sassone-Corsi, P. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol. Cell. Biol., 20: 8613-8622, 2000.
57. Muller, J. M., Isele, U., Metzger, E., Rempel, A., Moser, M., Pscherer, A., Breyer, T., Holubarsch, C., Buettner, R., and Schule, R. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J., 19: 359-369, 2000.
58. Pratt, W. B., and Toft, D. O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev., 18: 306-360, 1997.
59. Bach, I., Carriere, C., Ostendorff, H. P., Andersen, B., and Rosenfeld, M. G. A family of LIM domain-associated cofactors confers transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev., 11: 1370-1380, 1997.
60. Wadman, I. A., Osada, H., Grütz, G. G., Agulnick, A. D., Westphal, H., Forster, A., and Rabbitts, T. H. The Lim-only protein Lmo2 is a bridging molecular assembling an erythroid, DNA-binding complex which contains the TAL1, E47, GATA-1 and Ldb1/NL1 proteins. EMBO J., 16: 3145-3157, 1997.
61. Bach, I., Rhodes, S. J., Pearce, R. V., II, Heinzel, T., Gloss, B., Scully, K. M., Sawchenko, P. E., and Rosenfeld, M. G. P-Lim, a homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc. Natl. Acad. Sci. USA, 92: 2720-2724, 1995.
62. Bach, I., Rodroguez-Esteban, C., Carriere, C., Bhushan, A., Krones, A., Rose, D. W., Glass, C. K., Andersen, B., Belmonte, J. C. I., and Rosenfeld, M. G. RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat. Genet., 22: 394-399, 1999.
63. Glenn, D. J., and Maurer, R. A. MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein α-subunit gene expression. J. Biol. Chem., 274: 36159-36167, 1999.